Just Earth News | @justearthnews | 24 Nov 2020, 03:32 am Print
Sputnik V Moscow/Sputnik: Over 117,000 doses of Russia's coronavirus vaccine Sputnik V have been already released into the market, and there are plans to produce over 2 million doses by the end of the year, Deputy Prime Minister Tatyana Golikova said on Tuesday.
In August, Sputnik V, developed by the Gamaleya research institute, became the world's first registered vaccine against COVID-19. It is now in phase III post-registration clinical trials.
"Since the moment of Sputnik V state registration, over 117,000 doses of the vaccine have been released into civil circulation. Producers plan to produce over 2 million doses by the year end. Currently, immunization of high-risk groups, doctors and teachers is prioritized," Golikova told the coordination council of human rights commissioners.
- New research reveals why staying active could protect you from cancer
- AI-assisted heart scan analysis identifies muscle quality as predictor of heart health
- Shocking Shift: Study shows blood pressure and cholesterol levels in adults over 40 with obesity increasingly similar to adults with normal BMI
- Women who do this type of exercise may protect their hearts better, says study
- Viral scroll addiction? Study links short videos to anxiety, stress, and attention issues
